Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 12

Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model

Total article views   HTML views PDF downloads Totals
9,054 Dovepress* 7,510+ 1,749 9,259
PubMed Central* 1,544 564 2,108
Totals 9,054 2,313 11,367
*Since 24 March 2017
Total mentioned Facebook Delicious Reddit Twitter Others
6 1 0 0 1 4

View citations on PubMed Central and Google Scholar